CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled
Drug / intervention
Intraocular gas (C3F8)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03677869
NCT03677869N/ACompleted
CompareCT.gov

Single-Arm Study Assessing the Effects of Pneumatic Vitreolysis on Macular Hole

Jaeb Center for Health Research·interventional·Posted Sep 19, 2018·Updated Sep 19, 2022

In Brief

A clinical study evaluating Intraocular gas (C3F8) for Vitreomacular Traction (VMT) and Full-thickness Macular Holes (MH). Completed, enrolled 36 participants across 45 sites.

Detailed Summary

Eyes with vitreomacular traction (VMT) and full-thickness macular holes (MH) will be enrolled into a non-randomized cohort treated with pneumatic vitreolysis (PVL) to determine the proportion with VMT release and MH closure and to assess factors associated with success.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVitreomacular Traction (VMT), Full-thickness Macular Holes (MH)
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Eye Institute (NEI)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 19, 2018
Enrollment StartNov 14, 2018
Primary CompletionMar 16, 2020
Study CompletionJul 22, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.8 years ago

Interventions

Intraocular gas (C3F8)device

Intraocular gas (C3F8) injection